Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Safety monitoring and information (125)
- Compliance and enforcement (33)
- Import and export (30)
- Shortages and supply disruptions (16)
- Sunscreens (9)
- Advertising (6)
- COVID-19 (5)
- Labelling and packaging (4)
- Weight loss products (4)
- Breast implant hub (3)
- Manufacturing (3)
- Legislation (2)
- Cosmetics (1)
- Metal-on-metal hip replacement implants hub (1)
Type of content
Search
469 result(s) found, displaying 301 to 325
-
Safety alerts
-
Safety alerts
-
Safety alertsAdvice is available for the use of 2014 seasonal flu vaccines in children, with age-specific recommendations.
-
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alertsQuestions and answers about Dextropropoxyphene
-
Safety alerts
-
Market actions
-
Safety alerts
-
Safety alertsPhen Tabz tablets are banned in Australia because they contain a hidden, dangerous chemical (DMAA) that can seriously harm your health.
-
-
Safety alerts
-
Safety alertsNew conditions for Di-Gesic and Doloxene (dextropropoxyphene) took effect on 10 October 2013 to ensure safe use, changing how these pain-killers are prescribed and supplied.
-
Safety alertsThe TGA has tested two samples of a product labelled Prosolution tablets and found that one counterfeit sample contained tadalafil and sildenafil.
-
Safety alerts
-
Safety alerts
-
Safety alertsNew conditions on Di-Gesic and Doloxene (dextropropoxyphene) will change how these pain-killers are prescribed and supplied to ensure safe use from 10 October 2023.
-
Safety alerts